Search research articles
Contact Us
Filters
Showing results (61-70 of 429) with videos related to
Page
of 43
Sort By:
Expert Opinion on Pharmacotherapy
|
June 24, 2008
Quality of life in hypertension management using olmesartan in primary care
André C Schmidt, Peter Bramlage, Roger Limberg, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
July 4, 2014
Clinical significance of conduction disturbances after aortic valve intervention: current evidence
Manuel Martinez-Selles, Peter Bramlage, Martin Thoenes, et al.
Interactive Cardiovascular and Thoracic Surgery
|
May 29, 2019
Minimizing the risk for left ventricular rupture during transcatheter aortic valve implantation by reducing the presence of stiff guidewires in the ventricle
Niels Erik Nielsen, Julia Baranowska, Peter Bramlage, et al.
Diabetes & Vascular Disease Research
|
November 15, 2015
Incidence, characteristics and impact of hypoglycaemia in patients receiving intensified treatment for inadequately controlled type 2 diabetes mellitus
Diethelm Tschöpe, Peter Bramlage, Steffen Schneider, et al.
Vascular Health and Risk Management
|
December 11, 2008
Effects of the vasodilating beta-blocker nebivolol on smoking-induced endothelial dysfunction in young healthy volunteers
André C Schmidt, Burkhard Flick, Elke Jahn, et al.
Cardiovascular Diabetology
|
February 4, 2015
A real world comparison of sulfonylurea and insulin vs. incretin-based treatments in patients not controlled on prior metformin monotherapy
Anselm K Gitt, Peter Bramlage, Steffen Schneider, et al.
Vascular Health and Risk Management
|
June 23, 2007
Role of the vasodilator peptide angiotensin-(1-7) in cardiovascular drug therapy
Christoph Schindler, Peter Bramlage, Wilhelm Kirch, et al.
Respiration; International Review of Thoracic Diseases
|
December 5, 2014
Current perspectives on the contribution of inhaled corticosteroids to an increased risk for diabetes onset and progression in patients with chronic obstructive pulmonary disease
Felix J F Herth, Peter Bramlage, Dirk Müller-Wieland
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
February 5, 2021
Effectiveness and Safety of Switching Rapid-Acting Insulins to Insulin Glulisine in Patients with Diabetes: The Observational IGLU-S Study
Jochen Seufert, Martin Pfohl, Anja Borck, et al.
Cancer Chemotherapy and Pharmacology
|
May 13, 2015
Targeted therapies for treatment of renal cell carcinoma: recent advances and future perspectives
Joan Minguet, Katherine H Smith, Carsten P Bramlage, et al.
Page
of 43
Search research articles
Search
Showing results (61-70 of 429) with videos related to
Sort By:
Page
of 43
Expert Opinion on Pharmacotherapy
|
June 24, 2008
Quality of life in hypertension management using olmesartan in primary care
André C Schmidt, Peter Bramlage, Roger Limberg, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
July 4, 2014
Clinical significance of conduction disturbances after aortic valve intervention: current evidence
Manuel Martinez-Selles, Peter Bramlage, Martin Thoenes, et al.
Interactive Cardiovascular and Thoracic Surgery
|
May 29, 2019
Minimizing the risk for left ventricular rupture during transcatheter aortic valve implantation by reducing the presence of stiff guidewires in the ventricle
Niels Erik Nielsen, Julia Baranowska, Peter Bramlage, et al.
Diabetes & Vascular Disease Research
|
November 15, 2015
Incidence, characteristics and impact of hypoglycaemia in patients receiving intensified treatment for inadequately controlled type 2 diabetes mellitus
Diethelm Tschöpe, Peter Bramlage, Steffen Schneider, et al.
Vascular Health and Risk Management
|
December 11, 2008
Effects of the vasodilating beta-blocker nebivolol on smoking-induced endothelial dysfunction in young healthy volunteers
André C Schmidt, Burkhard Flick, Elke Jahn, et al.
Cardiovascular Diabetology
|
February 4, 2015
A real world comparison of sulfonylurea and insulin vs. incretin-based treatments in patients not controlled on prior metformin monotherapy
Anselm K Gitt, Peter Bramlage, Steffen Schneider, et al.
Vascular Health and Risk Management
|
June 23, 2007
Role of the vasodilator peptide angiotensin-(1-7) in cardiovascular drug therapy
Christoph Schindler, Peter Bramlage, Wilhelm Kirch, et al.
Respiration; International Review of Thoracic Diseases
|
December 5, 2014
Current perspectives on the contribution of inhaled corticosteroids to an increased risk for diabetes onset and progression in patients with chronic obstructive pulmonary disease
Felix J F Herth, Peter Bramlage, Dirk Müller-Wieland
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
February 5, 2021
Effectiveness and Safety of Switching Rapid-Acting Insulins to Insulin Glulisine in Patients with Diabetes: The Observational IGLU-S Study
Jochen Seufert, Martin Pfohl, Anja Borck, et al.
Cancer Chemotherapy and Pharmacology
|
May 13, 2015
Targeted therapies for treatment of renal cell carcinoma: recent advances and future perspectives
Joan Minguet, Katherine H Smith, Carsten P Bramlage, et al.
Page
of 43